<DOC>
	<DOCNO>NCT02397447</DOCNO>
	<brief_summary>The hypoglycemic effect Momordica Charantia evaluate clinical trial patient type 2 diabetes mellitus . Important reduction fast plasma glucose , glycated hemoglobin ( A1C ) , fructosamine observe . It unknown whether improvement due improvement insulin sensitivity insulin secretion . The purpose study evaluate effect administration Momordica Charantia insulin sensitivity insulin secretion patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Effect Momordica Charantia Administration Type 2 Diabetes Mellitus , Insulin Sensitivity Insulin Secretion</brief_title>
	<detailed_description>A randomized , double-blind , placebo control clinical trial carry 24 patient diagnosis diabetes mellitus type 2 accord criterion American Diabetes Association . Patients assign two different arm : one group receive Momordica Charantia , 2 capsule 500 mg twice daily breakfast dinner 90 day placebo , scheme treatment . An oral glucose tolerance test perform intervention . Matsuda index , Stumvoll index Insulinogenic index calculate assess insulin sensitivity insulin secretion . Other clinical laboratory parameter evaluate include : Body weight , body mass index , waist circumference , blood pressure , body fat percentage , fast plasma glucose , A1C , creatinine , lipid profile liver transaminase .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>Diagnosis diabetes mellitus type 2 accord criterion American Diabetes Association ( &lt; 5 year ) , without pharmacological treatment ( oral antidiabetic drug insulin ) least three month enter study Fasting glucose : &lt; 210 mg/dl A1C : 79 % Body mass index : 2534.9 kg/m2 Body weight without variation 5 % last three month enter study Women childbearing year must contraceptive method Letter consent release sign patient Pregnant suspect pregnant woman Woman breastfeed Medications know affect metabolism glucose insulin Personal history liver renal disease Hypertension , thyroid cardiovascular disease decompensated Total cholesterol &gt; = 240mg/dl , triglyceride &gt; =400mg/dl , glomerular filtration rate &lt; =60ml/min liver transaminases &gt; =2.5 upper normal limit</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Momordica Charantia</keyword>
	<keyword>Insulin secretion</keyword>
	<keyword>Insulin sensitivity</keyword>
</DOC>